Epidarex Capital

Epidarex Capital is a transatlantic venture capital firm focused on building breakthrough life science companies in emerging hubs. The firm leverages its deep scientific and industry networks to create exceptional value and shared success, catalyzing innovation in health science and technology.

Epidarex Capital

Epidarex Capital

Portfolio

Apellis Pharmaceuticals Inc.

Focused on developing complement immunotherapy for autoimmune diseases.

#Biotechnology

Edinburgh Molecular Imaging Ltd

Awarded Innovate UK Grant for colorectal cancer lesion detection.

#Medical Imaging

Harpoon Medical

Focused on minimally invasive mitral valve repair.

#Medical Devices

Caldan Therapeutics Ltd

Developing novel therapeutics targeting free fatty acid receptors for type 2 diabetes.

#Pharmaceuticals

Topas Therapeutics GmbH

Focused on treating immunological disorders.

#Biotechnology

Mironid Ltd

Leader in cell signalling directed drug development.

#Biotechnology